← Scroll for more →
Financial Statements — PSIG
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 8.94 | 6.99 | 8.16 |
| Short-term Investments | 4.98 | -- | -- |
| Accounts Receivable | 9.45 | 5.32 | 12.80 |
| Total Current Assets | 30.11 | 14.37 | 24.40 |
| Property, Plant & Equipment | 4.32 | 0.11 | 0.13 |
| Total Non-current Assets | 4.42 | 1.21 | 0.26 |
| Total Assets | 34.53 | 15.57 | 24.65 |
| Accounts Payable | 10.29 | 3.98 | 11.31 |
| Short-term Debt | 4.74 | -- | -- |
| Total Current Liabilities | 38.13 | 4.53 | 13.83 |
| Long-term Debt | 3.63 | -- | -- |
| Total Non-current Liabilities | 0.04 | 0.03 | 0.03 |
| Total Liabilities | 38.17 | 4.53 | 13.86 |
| Retained Earnings | (15.08) | (0.28) | 0.13 |
| Total Stockholder Equity | (3.77) | 10.92 | 10.67 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 23.15 |
| Cost of Revenue | 22.98 |
| Gross Profit | 0.21 |
| Selling, General & Admin | 2.16 |
| Total Operating Expenses | 2.16 |
| Operating Income | (1.95) |
| Pretax Income | (0.42) |
| Net Income | (0.42) |
| Basic EPS | (0.13) |
| Diluted EPS | (0.13) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | (0.82) |
| Capital Expenditures | 1.01 |
| Free Cash Flow* | (1.83) |
| Investing Cash Flow | (1.01) |
| Financing Cash Flow | 0.03 |
← Scroll for more columns →
* Derived from reported values